Product Name

  • Name

    bis[1-deoxy-1-(methylammonio)-D-glucitol] 3,3'-(adipoyldiimino)bis[2,4,6-triiodo-5-(N-methylcarbamoyl)benzoate]

  • EINECS
  • CAS No. 54605-45-7
  • Density
  • Solubility
  • Melting Point
  • Formula C24H20I6N4O8•2C7H17NO5
  • Boiling Point
  • Molecular Weight 1644.38
  • Flash Point
  • Transport Information
  • Appearance
  • Safety Poison by an unspecified route. Moderately toxic by intracerebral route. Human systemic effects by parenteral route: muscle spasms, blood pressure depression and musculo-skeletal changes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of I− and NOx.
  • Risk Codes
  • Molecular Structure Molecular Structure of 54605-45-7 (bis[1-deoxy-1-(methylammonio)-D-glucitol] 3,3'-(adipoyldiimino)bis[2,4,6-triiodo-5-(N-methylcarbamoyl)benzoate])
  • Hazard Symbols
  • Synonyms
  • PSA 431.32000
  • LogP 2.08120

Iocarmate meglumine Chemical Properties

IUPAC Name: 3-[[6-[[3-Carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]amino]-6-oxo-hexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
Synonyms of Iocarmate meglumine (CAS NO.54605-45-7) : Bis(1-Deoxy-1-(methylammonio)-D-glucitol) 3,3'-(adipoyldiimino)bis(2,4,6-triiodo-5-(N-methylcarbamoyl)benzoate) ; bis[1-Deoxy-1-(methylammonio)-D-glucitol] 3,3'-(adipoyldiimino)bis[2,4,6-triiodo-5-(N-methylcarbamoyl)benzoate]
InChI:InChI=1/C24H20I6N4O8.2C7H17NO5/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42;2*1-8-2-4(10)6(12)7(13)5(11)3-9/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42);2*4-13H,2-3H2,1H3
CAS NO:54605-45-7
Molecular Formula:C38H54I6N6O18
Molecular Weight :1644.2916
Molecular Structure :
EINECS: 259-252-7
Flash Point: 851.1 °C
Enthalpy of Vaporization: 238.89 kJ/mol
Boiling Point: 1483.7 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°
 

Iocarmate meglumine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intracrebral 697mg/kg (697mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
mouse LD50 intravenous 10900mg/kg (10900mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
mouse LD50 oral > 16gm/kg (16000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
mouse LD50 subcutaneous > 16gm/kg (16000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
rabbit LD50 unreported 67600ug/kg (67.6mg/kg)   Journal of the American College of Toxicology. Vol. 9, Pg. 563, 1990.
rat LD50 intracrebral 610mg/kg (610mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
rat LD50 intravenous 13300mg/kg (13300mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
rat LD50 oral > 16gm/kg (16000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
rat LD50 subcutaneous > 16gm/kg (16000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974.
rat LD50 unreported 74100ug/kg (74.1mg/kg)   Journal of the American College of Toxicology. Vol. 9, Pg. 563, 1990.
women TDLo parenteral 140mg/kg (140mg/kg) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

MUSCULOSKELETAL: OTHER CHANGES		 British Medical Journal. Vol. 1, Pg. 692, 1978.

Iocarmate meglumine Safety Profile

Poison by an unspecified route. Iocarmate meglumine (CAS NO.54605-45-7) is moderately toxic by intracerebral route. Human systemic effects by parenteral route: muscle spasms, blood pressure depression and musculo-skeletal changes. An experimental teratogen. Experimental reproductive effects. When Iocarmate meglumine (CAS NO.54605-45-7) is heated to decomposition, it emits toxic fumes of I− and NOx.

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View